Mouse Models of Retinal Detachment in the MICRON Literature

About the MICRON Research Literature

These research pages organize published studies using MICRON imaging systems by animal species and the disease or condition investigated.

All publication counts and figures reflect the complete indexed research collection.

Explore related studies through the MICRON Research Hubs or search the complete publication collection in the reSEARCH portal.

Understanding Retinal Detachment

Retinal detachment is separation of the neurosensory retina from the retinal pigment epithelium beneath it, which separates photoreceptors from RPE support and increases their distance from the choroidal circulation on which the outer retina largely depends.

It is classified by how the separation arises:

  • Rhegmatogenous, following a break in the retina
  • Tractional, where contracting membrane pulls the retina away
  • Exudative, where fluid collects beneath a retina that is intact

Separation also arises as a feature of disease processes studied for other reasons, exudative beneath neovascular, inflammatory or tumor lesions and tractional alongside fibrovascular proliferation, so the same finding is recorded in literatures whose subject is something else.

Retinal Detachment in Experimental Research

Separation and subretinal fluid are directly visible in cross-section, while photoreceptor loss and reduced retinal function provide structural and functional consequences that can be followed with imaging and electrophysiology.

Animal work on detachment divides by eye size:

  • In a small eye a separation can be produced reproducibly, for instance by a subretinal injection that lifts the retina off its epithelium, and what such a preparation supplies is mechanism, meaning the death of photoreceptors deprived of their epithelium, the glial and immune response that accompanies it, and whether an intervention alters either
  • In an eye approaching human dimensions the same separation can be created and then repaired with instruments close to those used clinically, and what those preparations supply is the procedure: how the retina is reattached, how a break is sealed, and whether a device or a maneuver works in a globe with the working space to accommodate it

What this work does not supply is the axis on which a human detachment is judged, because whether the macula has separated governs both urgency and how much vision returns after anatomically successful repair, and the species used here have no macula and cannot report what they see, so acuity and visual field outcomes have no direct counterpart in them.

Mouse Models of Retinal Detachment

The mouse carries most of this work. Transgenic and knockout lines allow a pathway to be removed or overexpressed, and cost, availability, short generation time and a large body of background data reinforce the choice.

A genetic manipulation constrains rather than isolates a mechanism: developmental compensation and pleiotropy remain possible.

Published MICRON Research: Retinal Detachment in Mice

This page lists 39 papers from the MICRON literature, published 2012 to 2026, that study retinal detachment in mice.

Of these publications:

  • 37 studies used mice as the primary retinal detachment disease model.
  • 2 studies used healthy animals to assess pharmacokinetics, drug delivery, or tolerability.

Scope of the literature collection: Publication counts reflect studies identified and indexed in the MICRON research corpus. This collection is not intended to represent an exhaustive review of all published retinal detachment research.

Which imaging and experimental techniques are used in these studies?

Technique counts are paper-level co-occurrences and do not necessarily indicate that a technique was applied to the focal species or focal disease model.

Capabilities and Limitations of Imaging Techniques

A summary of what each imaging technique listed above can measure, the information it provides, and its limitations in research applications.

Optical Coherence Tomography

Optical coherence tomography provides high-resolution, cross-sectional images of ocular tissues in the living eye, allowing researchers to visualize structures at different depths. OCT is particularly useful for measuring tissue thickness, identifying structural abnormalities, and assessing the location and extent of tissue changes.

As a non-invasive imaging technique, OCT enables repeated measurements in the same eye over time, supporting longitudinal studies of disease progression and treatment response. Although OCT provides detailed structural information, it does not directly measure cellular activity or visual function. Tissue that appears structurally normal may still have functional abnormalities, making OCT a valuable companion to functional assessments such as electroretinography (ERG).

Electroretinography

Records the retina's electrical response to light, giving component-sensitive information about outer- and inner-retinal function. It measures function directly, which no structural method does. Full-field ERG sums across the whole retina, so a small lesion can leave the trace unchanged; focal and multifocal variants trade signal amplitude for spatial resolution.

Intravitreal Injection / Delivery

Injection into the vitreous places a substance directly into the vitreous at a known administered dose and chosen time, reducing but not eliminating systemic exposure. The injectate may be a therapeutic compound, cell preparation or viral vector, or an agent used to create the model, such as a toxin, vasoactive or excitotoxic compound, or infectious inoculum. The route bypasses surface-delivery barriers and provides direct access to the vitreous and posterior segment, but the concentration reached in a particular ocular tissue depends on distribution and clearance and is not fixed by the injected dose alone. It is invasive and discrete: each repeat dose or challenge requires another injection, and vehicle- or sham-injected controls can help separate effects of the injectate from effects of the procedure.

Topical Ophthalmic Drug Delivery

A compound applied as drops to the ocular surface. It is non-invasive and repeatable, so it supports frequent dosing without a procedure for each dose. What the route has to establish depends on the target: for an ocular-surface target, residence time and penetration into the surface tissue are the main barriers; for an intraocular anterior-segment target, the compound must cross ocular-surface and corneal or conjunctival barriers and reach an intraocular concentration sufficient for the experiment; for a posterior-segment target, additional ocular barriers separate the surface from the target and posterior-segment exposure is harder to establish.

Fundus Fluorescein Angiography

Fundus fluorescein angiography uses an injected fluorescent dye to visualize blood flow through the retinal and choroidal circulation. Sequential images show how vessels fill, identify areas of reduced or absent perfusion, and reveal dye leakage associated with vascular abnormalities.

This technique is particularly useful for evaluating vascular perfusion, blood-retinal barrier integrity, and abnormal vessel growth. Fluorescein angiography primarily shows dye distribution rather than the surrounding retinal tissue. It provides a two-dimensional (en face) view in which vessels at different depths may overlap. Cross-sectional and cellular structural details require other imaging methods, such as optical coherence tomography (OCT) or optical coherence tomography angiography (OCT-A). Vascular abnormalities that do not affect dye filling or produce leakage may also remain undetected.

Laser Photocoagulation Models

A laser lesion provokes a reproducible, quantifiable injury at a known time and place. Wavelength, power, duration, spot size, pulse mode, focus and lesion location together determine the injury produced, allowing laser exposure to be configured for different experimental endpoints. It is an induced injury, not the disease: it produces a lesion directly, bypassing the process that gives rise to comparable damage in patients.

AAV-Mediated Ocular Gene Delivery

An adeno-associated viral vector delivers genetic material to ocular cells, and a single administration can support long-lived transgene expression. That persistence is useful for gene augmentation and sustained therapeutic-protein expression; AAV can also deliver gene-silencing or genome-editing cargo, where long-lived expression of the editing machinery may be unnecessary or undesirable. Capsid and route of delivery jointly determine which cells are reached, so different delivery routes and vector designs give different distributions.

Ocular Blast Injury

Experimental ocular blast models expose the eye, or in some paradigms the head with ocular outcomes measured, to a controlled overpressure wave at a known time. Peak pressure, waveform and impulse, exposure number, orientation and interval help determine the loading delivered to the eye. A blast wave can injure multiple ocular compartments, including anterior structures, retina and optic nerve, although the pattern and severity depend on the exposure paradigm and the animal. Eye-directed paradigms that shield the head and body are used to isolate primary blast effects on the eye; head-directed or less-confined paradigms may also involve central nervous-system and other traumatic-brain-injury mechanisms and should not be treated as equivalent. Because the exposure is known, interventions can be tested against it and sham exposures can help distinguish effects of the pressure wave from handling or the experimental procedure. Apparatus design, waveform, positioning and shielding materially affect the delivered exposure, so nominal pressure values or exposure counts should not be assumed directly comparable across laboratories or equivalent to human blast exposure without physical characterization.

Which MICRON systems and add-ons appear?

Which MICRON systems and add-ons appear?
Instrument Papers
MICRON III 19
MICRON IV 19
Image-Guided OCT 14
Insight Software 3
Ganzfeld ERG System 1
Image-Guided Focal ERG 1
Image-Guided Laser 1
MICRON (Unspecified) 1
MICRON II 1

Which strains and genetic lines are used?

Which strains and genetic lines are used?
Strain Papers Reported as
C57BL/6J 18 C57BL/6 J
C57BL/6 8 C57BL6
Asah1P361R/P361R 1
B6Albino 1
BALB/c 1
C57BL/6N 1
C57BL/J 1
CB6-Tg[TagRb]1Plm/Mmjax (LHBetaTag) 1
NOD-SCID 1
P1.hMR transgenic 1
SCID 1
Swiss-nude 1
ddY 1
rd1 1

Which other species appear alongside?

Which other species appear alongside?
Species Papers
Rabbit 2
Swine / Domestic Pig 1

What other conditions are recorded on the same papers?

What other conditions are recorded on the same papers?
Disease Papers
Retinal Degeneration (General) 15
Retinal Neovascularization (General) 8
Retinal Pigment Epithelium Dysfunction 8
Age-Related Macular Degeneration (General) 7
Age-Related Macular Degeneration (Wet/Neovascular) 6
Diabetic Retinopathy 6
Retinal Ganglion Cell Degeneration 6
Retinal Hemorrhage 6
Choroidal Neovascularization 5
Retinitis Pigmentosa (RP) 5
Proliferative Vitreoretinopathy 4
Cataract (General) 3
Diabetic Retinal Neurodegeneration 3
Epiretinal Membrane 3
Retinal Vein Occlusion (RVO) 3
Retinopathy of Prematurity 3
Corneal Opacity / Scarring 2
Light-Induced Retinal Degeneration 2
Optic Atrophy (General) 2
Retinal Artery Occlusion 2
Retinal Dysplasia 2
Retinoblastoma 2
Stargardt Disease 2
Acute Retinal Necrosis / Herpetic Retinitis 1
Age-Related Macular Degeneration (Dry/Atrophic) 1
Central Serous Chorioretinopathy 1
Color Vision Defects 1
Conjunctival Neoplasms / OSSN 1
Corneal Neovascularization 1
Diabetes Mellitus, Type 1 1
Glaucoma (General) 1
Iritis / Iridocyclitis 1
Leber Congenital Amaurosis (LCA) 1
Ocular Hypertension 1
Optic Neuropathy (General) 1
Retinal Neurodegeneration in Systemic Disease 1
Uveal Melanoma 1
Uveitis (General) 1
Vitreous Detachment 1

Which MICRON configurations appear in this work?

Configurations recorded in these papers, and the techniques recorded alongside them.

Which MICRON configurations appear in this work?
MICRON configuration Papers Most frequent techniques recorded alongside
MICRON III 19 Optical Coherence Tomography (13), Electroretinography (7), Intravitreal Injection / Delivery (7)
MICRON IV 19 Optical Coherence Tomography (14), Electroretinography (10), Intravitreal Injection / Delivery (8)
Image-Guided OCT 14 Optical Coherence Tomography (13), Electroretinography (9), Topical Ophthalmic Drug Delivery (6)
Insight Software 3 Electroretinography (3), Intravitreal Injection / Delivery (2), Laser Photocoagulation Models (2)
Ganzfeld ERG System 1 Electroretinography (1), Optical Coherence Tomography (1)
Image-Guided Focal ERG 1 Electroretinography (1)
Image-Guided Laser 1 Electroretinography (1), Intravitreal Injection / Delivery (1), Laser Photocoagulation Models (1)
MICRON (Unspecified) 1 Electroretinography (1), Optical Coherence Tomography (1), Topical Ophthalmic Drug Delivery (1)
MICRON II 1 Electroretinography (1), Fundus Fluorescein Angiography (1), Optical Coherence Tomography (1)

The papers

The papers
Year Title Journal Role of focal species MICRON products Links
2026 Colony-stimulating factor 1 receptor inhibition is neuroprotective to photoreceptors in retinal detachment. Cell Death & Disease Disease model MICRON IV DOI · reSEARCH
2026 Crop-OCT: a Fully Integrated Imageomics Pipeline to Identify Regional and Focal Retinopathy in Murine Models bioRxiv Disease model Image-Guided OCT, MICRON IV DOI · reSEARCH
2025 cGAMP promotes inner blood-retinal barrier breakdown through P2RX7-mediated transportation into microglia. Journal of Neuroinflammation Disease model MICRON IV DOI · reSEARCH
2025 Loss of a primary cilia protein ARL13B promotes TGFβ-1 induced EMT of RPE in proliferative vitreoretinopathy via increasing Smad3 expression. Frontiers in Cell and Developmental Biology Disease model MICRON IV DOI · reSEARCH
2025 Novel Role of Copper Transporter CTR1 and Therapeutic Potential of Copper Chelators in Retinal Ischemia-Reperfusion Injury. Investigative Ophthalmology & Visual Science Disease model Image-Guided OCT, MICRON III DOI · reSEARCH
2025 STING activates ZBP1-mediated PANoptosis to defend against HSV-1 retinal infection. Journal of Neuroinflammation Disease model MICRON IV DOI · reSEARCH
2024 Heterogeneity in the progression of retinal pathologies in mice harboring patient mimicking Impg2 mutations. Human Molecular Genetics Disease model Image-Guided OCT, Insight Software, MICRON IV DOI · reSEARCH
2023 Kamuvudine-9 Protects Retinal Structure and Function in a Novel Model of Experimental Rhegmatogenous Retinal Detachment. Investigative Ophthalmology & Visual Science Disease model Ganzfeld ERG System, Image-Guided OCT, MICRON IV DOI · reSEARCH
2023 AAV2-antiVEGFscFv gene therapy for retinal neovascularization. Molecular Therapy. Methods & Clinical Development Disease model MICRON III DOI · reSEARCH
2023 Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy. Investigative Ophthalmology & Visual Science Disease model MICRON III DOI · reSEARCH
2022 Deficiency in Lyst function leads to accumulation of secreted proteases and reduced retinal adhesion. PLoS ONE Disease model Image-Guided OCT, MICRON III DOI · reSEARCH
2022 A Splicing Mutation in Slc4a5 Results in Retinal Detachment and Retinal Pigment Epithelium Dysfunction. International Journal of Molecular Sciences Disease model MICRON III, MICRON IV DOI · reSEARCH
2021 In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma. Experimental Eye Research Disease model Image-Guided OCT, MICRON IV DOI · reSEARCH
2021 AAV-Mediated Expression of Human VEGF, TNF-α, and IL-6 Induces Retinal Pathology in Mice. Translational Vision Science & Technology Disease model MICRON IV DOI · reSEARCH
2021 Myosin 1f-mediated activation of microglia contributes to the photoreceptor degeneration in a mouse model of retinal detachment. Cell Death & Disease Disease model Image-Guided OCT, MICRON (Unspecified) DOI · reSEARCH
2021 Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction. Molecular Metabolism Disease model Image-Guided OCT, MICRON III DOI · reSEARCH
2021 Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium. International Journal of Molecular Sciences Disease model Image-Guided OCT, MICRON III DOI · reSEARCH
2020 Low retinal toxicity of intravitreal carboplatin associated with good retinal tumour control in transgenic murine retinoblastoma. Clinical & Experimental Ophthalmology Disease model Image-Guided OCT, MICRON IV DOI · reSEARCH
2020 A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells. Translational Vision Science & Technology Disease model MICRON III DOI · reSEARCH
2019 Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment. The American Journal of Pathology Disease model MICRON IV DOI · reSEARCH
2019 Complement Factor H Mutation W1206R Causes Retinal Thrombosis and Ischemic Retinopathy in Mice. The American Journal of Pathology Disease model MICRON III DOI · reSEARCH
2019 Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization. Acta Biomaterialia Disease model MICRON III DOI · reSEARCH
2019 IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment. Journal of Neuroinflammation Disease model MICRON IV DOI · reSEARCH
2018 Clinically Relevant Outcome Measures for the I307N Rhodopsin Mouse: A Model of Inducible Autosomal Dominant Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science Disease model MICRON III DOI · reSEARCH
2018 AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration. Molecular Therapy Disease model MICRON III DOI · reSEARCH
2018 Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models. Scientific Reports Disease model MICRON III DOI · reSEARCH
2018 Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2Akita mouse. Stem Cell Research & Therapy Disease model Image-Guided OCT, Insight Software, MICRON IV DOI · reSEARCH
2017 Deletion of Endothelial Transforming Growth Factor-β Signaling Leads to Choroidal Neovascularization. The American Journal of Pathology Disease model MICRON III DOI · reSEARCH
2017 Plastic roles of pericytes in the blood-retinal barrier. Nature Communications Disease model Image-Guided Focal ERG, MICRON IV DOI · reSEARCH
2017 Advances in bone marrow stem cell therapy for retinal dysfunction. Progress in Retinal and Eye Research Healthy PK, delivery or tolerability MICRON III DOI · reSEARCH
2017 Looking for the Most Suitable Orthotopic Retinoblastoma Mouse Model in Order to Characterize the Tumoral Development. Investigative Ophthalmology & Visual Science Disease model MICRON IV DOI · reSEARCH
2017 A pharmacological approach in newly established retinal vein occlusion model. Scientific Reports Disease model Image-Guided Laser, Image-Guided OCT, Insight Software, MICRON IV DOI · reSEARCH
2017 OM-101 Decreases the Fibrotic Response Associated with Proliferative Vitreoretinopathy. Journal of Ophthalmology Disease model MICRON III DOI · reSEARCH
2017 Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration. mAbs Disease model MICRON III DOI · reSEARCH
2016 Retinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θ. Investigative Ophthalmology & Visual Science Disease model Image-Guided OCT, MICRON III DOI · reSEARCH
2016 Eye-Directed Overpressure Airwave-Induced Trauma Causes Lasting Damage to the Anterior and Posterior Globe: A Model for Testing Cell-Based Therapies. Journal of Ocular Pharmacology and Therapeutics Disease model MICRON IV DOI · reSEARCH
2015 Trans-Corneal Subretinal Injection in Mice and Its Effect on the Function and Morphology of the Retina. PLoS ONE Healthy PK, delivery or tolerability Image-Guided OCT, MICRON IV DOI · reSEARCH
2014 Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A. Angiogenesis Disease model MICRON III DOI · reSEARCH
2012 Preservation of cone photoreceptors after a rapid yet transient degeneration and remodeling in cone-only Nrl-/- mouse retina. The Journal of Neuroscience Disease model MICRON II DOI · reSEARCH

Browse all hubs at MICRON Research Hubs. The full corpus is searchable in the reSEARCH portal.

Last built 2026-11-10 from content tag hubs-content-2026-11-10 (ae06cfc); fact-sheet run sheets-20261110T111119Z. About these hubs Back to top